#mifepristone

#mifepristone

The U.S. Supreme Court justices did not appear ready to limit access to the abortion pill mifepristone, which has significant implications.

The FDA approved mifepristone in 2000 as a safe way to end early pregnancies, and the agency has monitored its safety for more than 20 years. [ more ]

Mifepristone and misoprostol combination is safe and effective for medication abortion.

Medication abortion is increasingly preferred, especially due to telemedicine options during the Covid-19 pandemic. [ more ]

The U.S. Supreme Court will hear a case on the future of mifepristone, a drug used in over half of all abortions in the U.S.

Mifepristone, when combined with misoprostol, offers a safe and effective method to terminate a first-trimester pregnancy. [ more ]

U.S. Supreme Court upholds access to mifepristone, a common abortion drug. [ more ]

The Supreme Court unanimously preserved access to mifepristone, a critical medication for abortions in the U.S. [ more ]

The Supreme Court unanimously preserved access to mifepristone, protecting abortion rights and FDA's authority. [ more ]

The safety of mifepristone is a central issue in the case challenging FDA approval.

Emergency room visits following medication abortion are not necessarily indicative of safety concerns. [ more ]

The Supreme Court is considering FDA regulations on mifepristone.

Pre-2016 rules could limit access to medication abortion. [ more ]

Access to mifepristone under threat

Governor Newsom warns of national abortion ban [ more ]

The Supreme Court case on mifepristone could impact FDA regulations broadly.

FDA oversight could face challenges affecting various medications and therapies. [ more ]

The Supreme Court will soon hear a case about the abortion drug mifepristone and its use in virtual appointments.

A study published in Nature Medicine provides support for the FDA's assessment that telehealth abortion is safe and effective. [ more ]

The Supreme Court has agreed to consider a challenge to access to mifepristone, the first drug used in medication abortion.

The outcome of this case could potentially leave open the possibility for a future Republican president to ban abortion nationwide without enacting new laws. [ more ]

Conservative challengers targeting FDA decisions on mifepristone could impact access to other medications.

Supreme court case on mifepristone could reshape abortion access and drug regulation in the US. [ more ]

Community pharmacies in states where abortion is legal are now able to fill prescriptions for the abortion pill mifepristone, which could help ease the burden on abortion clinics.

In Washington state, efforts are being made to train pharmacists to not only dispense abortion pills but also prescribe them in order to increase access to medication abortion. [ more ]

The Supreme Court upheld nationwide access to the abortion pill mifepristone despite a lawsuit aiming to restrict it, leading to unintended positive effects on abortion access and awareness. [ more ]

The U.S. Supreme Court upheld access to mifepristone, a key abortion drug, with Justice Kavanaugh's decision. [ more ]

Mifepristone access defended by Supreme Court against antiabortion challenge, critical for U.S. abortions. [ more ]

Publisher Sage retracted three abortion studies cited by anti-abortion groups in a legal case.

The retraction was based on problems with the studies' methods, analyses, presentation, and undisclosed conflicts of interest. [ more ]

The US Supreme Court will hear a case challenging access to abortion pills, which could have significant implications for reproductive healthcare.

The case involves the legality of mifepristone, the most common medication used in abortion procedures in the US. [ more ]

The US Supreme Court ruling in Alliance for Hippocratic Medicine v. FDA does not conclude FDA's exclusive authority over drug regulation, leaving room for future challenges. [ more ]